Emre B. Yildirim
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Large language models standardize the interpretation of complex oncology guidelines for brain metastases.
Journal: Communications medicine
Published: May 15, 2025
Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses.
Journal: BMJ open
Published: November 17, 2020
Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events.
Journal: BMJ open diabetes research & care
Published: June 19, 2020
Glucagon-like peptide-1 receptor expression in the human eye.
Journal: Diabetes, obesity & metabolism
Published: February 13, 2018
Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: November 13, 2016
Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.
Journal: Clinical colorectal cancer
Published: June 08, 2016
Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy.
Journal: Medical hypotheses
Published: February 03, 2016
Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma.
Journal: Clinical colorectal cancer
Published: January 28, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026